Oxali(IV)Fluors: fluorescence responsive oxaliplatin(IV) complexes identify a hypoxia-dependent reduction in cancer cells by Boulet, M, Bolland, H, Hammond, E, Sedgwick, A

Peroxynitrite activated drug conjugate systems based on a coumarin scaffold toward the application of theranostics by Odyniec, M, Han, H, Gardiner, J, Sedgwick, A, He, X, Bull, S, James, T

Fluorogenic platinum(iv) complexes as potential predictors for the design of hypoxia-activated platinum(iv) prodrugs by Marsh, J, Lina, Huang, S, Boulet, M, White, JRG, Martin, L, Yeomans, M, Han, H-H, Diez-Perez, I, Musgrave, R, Hammond, E, Sedgwick, A